These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 9809859

  • 1. The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response.
    Joordens RJ, Hijzen TH, Olivier B.
    Psychopharmacology (Berl); 1998 Oct; 139(4):383-90. PubMed ID: 9809859
    [Abstract] [Full Text] [Related]

  • 2. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B.
    Eur J Pharmacol; 1997 May 01; 325(2-3):145-53. PubMed ID: 9163561
    [Abstract] [Full Text] [Related]

  • 3. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 01; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 4. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 5. 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists.
    Moore NA, Rees G, Sanger G, Perrett L.
    Pharmacol Biochem Behav; 1993 Sep 17; 46(1):141-3. PubMed ID: 8255903
    [Abstract] [Full Text] [Related]

  • 6. Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test.
    Zhao Y, Bijlsma EY, Ter Heegde F, Verdouw MP, Garssen J, Newman-Tancredi A, Groenink L.
    Psychopharmacology (Berl); 2019 Apr 17; 236(4):1171-1185. PubMed ID: 30539269
    [Abstract] [Full Text] [Related]

  • 7. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M, Samanin R.
    Psychopharmacology (Berl); 2000 Apr 17; 149(3):259-68. PubMed ID: 10823407
    [Abstract] [Full Text] [Related]

  • 8. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM, Wallsten CE, Jerning E, Hu PS, Deveney AM.
    Psychopharmacology (Berl); 1998 Oct 17; 139(4):300-10. PubMed ID: 9809851
    [Abstract] [Full Text] [Related]

  • 9. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
    De Vry J, Jentzsch KR.
    Eur J Pharmacol; 1998 Sep 11; 357(1):1-8. PubMed ID: 9788767
    [Abstract] [Full Text] [Related]

  • 10. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 11; 275(2):822-31. PubMed ID: 7473172
    [Abstract] [Full Text] [Related]

  • 11. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat.
    King CM, Gommans J, Joordens RJ, Hijzen TH, Maes RA, Olivier B.
    Eur J Pharmacol; 1997 May 01; 325(2-3):121-8. PubMed ID: 9163558
    [Abstract] [Full Text] [Related]

  • 12. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ, Rivet JM, Gobert A, Canton H, Veiga S, Bervoets K.
    J Pharmacol Exp Ther; 1994 Apr 01; 269(1):121-31. PubMed ID: 7909555
    [Abstract] [Full Text] [Related]

  • 13. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
    Hadrava V, Blier P, Dennis T, Ortemann C, de Montigny C.
    Neuropharmacology; 1995 Oct 01; 34(10):1311-26. PubMed ID: 8570029
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635.
    Cryan JF, Kelliher P, Kelly JP, Leonard BE.
    J Psychopharmacol; 1999 Oct 01; 13(3):278-83. PubMed ID: 10512084
    [Abstract] [Full Text] [Related]

  • 15. Synergistic enhancement of the acoustic startle reflex by dopamine D1 and 5-HT1A agonists and corresponding changes in c-Fos expression in the dorsal raphe of rats.
    Meloni EG, Davis M.
    Psychopharmacology (Berl); 2000 Sep 01; 151(4):359-67. PubMed ID: 11026743
    [Abstract] [Full Text] [Related]

  • 16. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB, Koek W.
    Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA, Nguyen HQ, Smith DL, Schechter LE.
    J Psychopharmacol; 2002 Jun 08; 16(2):145-52. PubMed ID: 12095073
    [Abstract] [Full Text] [Related]

  • 18. A behavioral mechanistic investigation of the role of 5-HT1A receptors in the mediation of rat maternal behavior.
    Li X, Ding X, Wu R, Chen L, Gao J, Hu G, Li M.
    Pharmacol Biochem Behav; 2018 Jun 08; 169():16-26. PubMed ID: 29649502
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of 5-HT1A receptor ligands by drug discrimination.
    Wolff MC, Leander JD.
    Eur J Pharmacol; 1997 Aug 27; 333(2-3):113-22. PubMed ID: 9314023
    [Abstract] [Full Text] [Related]

  • 20. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ.
    Psychopharmacology (Berl); 2000 Sep 27; 152(1):55-66. PubMed ID: 11041316
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.